Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Banks On ICDs To Spark Stock Growth; Index Slips In 2005

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific is counting on Guidant shareholders preferring its takeover offer to J&J's to regain Wall Street enthusiasm in the face of diminishing competitive advantages for Taxus and a 31% stock decline in 2005

You may also be interested in...



NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%

NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006

NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%

NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006

Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill

The House and Senate passed a deficit reduction bill that would authorize a gainsharing demonstration program at up to six sites beginning in 2007

Related Content

UsernamePublicRestriction

Register

MT023073

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel